Advisory Board CEO: It's 'business as usual, as much as possible'
Before The Advisory Board Co. (NASDAQ: ABCO) even began its second-quarter conference call Tuesday, CEO Robert Musslewhite warned analysts he wouldn't be answering questions about the one thing they likely wanted to ask about the most: the company's ongoing review of a possible sale.
Musslewhite did, however, agree to very briefly answer a question about how that process has been impacting business at the D.C. health care and education consultancy. His message: It's "business as usual, as much as…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Tina Reed Source Type: news
More News: Biotechnology | Conferences | Consultancies | Education | Health Management | Universities & Medical Training